Home / Site MapSite MapPagesHomePatients & FamiliesMetastatic Pancreatic Ductal Adenocarcinoma (mPDAC) Symptoms & TreatmentCoronary Microvascular Dysfunction Symptoms & TreatmentCritical Limb Ischemia and Buerger’s Disease Symptoms & TreatmentResearch & TechnologyCendR Platform® – Targeted penetration technology to enhance drug delivery to advanced solid tumorsCD34+ Cell TechnologyPublicationsAbout UsManagement TeamBoard of DirectorsPipelinePancreatic Cancer & Advanced Solid Tumors – LSTA1CareersContact UsActive Clinical Trials in Oncology and IschemiaPrivacy PolicyPipeline ProgramsDurvalumab, gemcitabine/nab-paclitaxel + LSTA1 (Australia)TPN Development Candidate (U.S.)XOWNA® (LSTA16) (U.S.)HONEDRA® (LSTA12) (Japan)LSTA201 (U.S.)No-Option Refractory Disabling AnginaManagementTariq ImamKristen K. Buck, MDJames NiscoJohn D. MendittoGail HollerGregory S. BerkinDavid J. Mazzo, PhDBoard Of DirectorsMohammad Azab, MD, MSc, MBAHeidi HensonCynthia L. FlowersSteven M. KloskGregory B. Brown, MDDavid J. Mazzo, PhD
